Oxford Asset Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-921
| Closed | -$283K | – | 2166 |
|
|
2019
Q3 | $283K | Buy |
921
+272
| +42% | +$83.6K | 0.01% | 1479 |
|
|
2019
Q2 | $207K | Buy |
649
+88
| +16% | +$28.1K | ﹤0.01% | 1548 |
|
|
2019
Q1 | $235K | Sell |
561
-3,020
| -84% | -$1.27M | 0.01% | 1466 |
|
|
2018
Q4 | $1.09M | Sell |
3,581
-844
| -19% | -$257K | 0.03% | 826 |
|
|
2018
Q3 | $1.62M | Buy |
4,425
+251
| +6% | +$91.6K | 0.03% | 783 |
|
|
2018
Q2 | $1.52M | Buy |
+4,174
| New | +$1.52M | 0.03% | 823 |
|
|
2018
Q1 | – | Sell |
-610
| Closed | -$261K | – | 1937 |
|
|
2017
Q4 | $261K | Buy |
610
+157
| +35% | +$67.2K | 0.01% | 1375 |
|
|
2017
Q3 | $147K | Buy |
+453
| New | +$147K | ﹤0.01% | 1456 |
|